Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Valerius

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Bone Marrow Transplantation|December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Frontiers in Immunology|February 15, 2019
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human NeutrophilsLouise W Treffers, Michel van Houdt, Christine W Bruggeman, et al.
HLA|June 27, 2024
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantationElisa Maria Amann, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Nature Communications|March 7, 2024
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteriaStian Foss, Siri A Sakya, Leire Aguinagalde, et al.
Bone Marrow Transplantation|May 1, 2021
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMTMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Blood Neoplasia|June 22, 2026
Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interferenceMarta Lustig, Maja Kowol, Alina M Hartmann, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Bone Marrow Transplantation|December 1, 2023
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Frontiers in Immunology|February 15, 2019
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human NeutrophilsLouise W Treffers, Michel van Houdt, Christine W Bruggeman, et al.
HLA|June 27, 2024
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantationElisa Maria Amann, Sowmya Gowdavally, Chrysanthi Tsamadou, et al.
Nature Communications|March 7, 2024
Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteriaStian Foss, Siri A Sakya, Leire Aguinagalde, et al.
Bone Marrow Transplantation|May 1, 2021
Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMTMohamed A Kharfan-Dabaja, Myriam Labopin, Ali Bazarbachi, et al.
Blood Neoplasia|June 22, 2026
Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interferenceMarta Lustig, Maja Kowol, Alina M Hartmann, et al.
Pageof 11